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A B S T R A C T
Objective: Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent for Kaposi's sarcoma
(KS), one of the most common cancers in Tanzania. We have investigated KSHV prevalence and factors
associated with KSHV infection in Tanzania.
Methods: This is a cross-sectional study of voluntary blood-donors from Dar es Salaam, Tanzania. Plasma
was screened for KSHV, HIV-1, HBV, HCV and Treponema pallidum (syphilis). Associations between KSHV
sero-status and risk factors were analyzed. Odds ratios (OR) and 95% confidence intervals (CI) are
reported to evaluate risk factors of KSHV infection. All tests were 2-tailed, and P-values <0.05 were
considered statistically significant.
Results: The overall KSHV seroprevalence was 56.9%. Significantly increased risk of KSHV infection was
detected in persons from the Lake and Central Zones (OR = 6.4, 95% CI = 1.6–25.3, P = 0.008 and OR = 5.7,
95% CI = 1.0–32.5, P = 0.048 respectively). A trend toward increased risk of KSHV infection with HIV-1 co-
infection was not significant (OR = 2.8, 95% CI = 1.0–8.0, P = 0.06). Seroreactivity to T. pallidum was
surprisingly high (14.9%).
Conclusion: The prevalence of KSHV infection and syphilis was high among Tanzanian blood-donors. The
most common transfusion-transmissible infections did not associate with KSHV infection. Regions of
focal KSHV infection need further investigation for underappreciated risk factors.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
1. Introduction
Kaposi's sarcoma-associated herpesvirus (KSHV) is etiologically
linked with Kaposi's sarcoma (KS), primary effusion lymphoma
(PEL) and multicentric Castleman's disease (MCD) (Chang et al.,
1994; Cesarman et al., 1995; Moore and Chang, 1995; Soulier et al.,
1995). The virus is unequally distributed geographically with KSHV
infection endemic in sub-Saharan Africa (SSA), some parts of
Eastern Europe and Mediterranean and some ethnicities in China
(Dedicoat and Newton, 2003; de Sanjose et al., 2009; Dollard et al.,
2010; Zheng et al., 2017). Consequently, the burden of KS is highest
in SSA where two distinct forms, African endemic KS (EnKS), and
HIV-1-associated/Epidemic KS (EpKS) are common. Levels of EnKS
continue relatively unchanged from pre-HIV-1 epidemic levels of 4
to 10% of all sub-Saharan cancers (Cook-Mozaffari et al., 1998);
whereas, EpKS is now the most common cancer in people living
with HIV-1 infection in SSA (Bohlius et al., 2014; Rohner et al.,
2014; Ngalamika et al., 2015; Semeere et al., 2016). While KSHV
prevalence is high in Uganda and Zambia, two neighboring
countries to Tanzania, the prevalence of this infection is not
clear in Tanzania (Minhas and Wood, 2014; Newton et al., 2018b).
Infection with KSHV is life-long, and most infections detected in
African adults occurred during childhood (Mbulaiteye et al., 2003;
Minhas et al., 2008a; Butler et al., 2009b; Cao et al., 2014b;
Nalwoga et al., 2018). The majority of KSHV infection occurs in
childhood resulting in about 50% seroprevalence in sub-Saharan
children before their fourth birthday (Minhas et al., 2008a). Saliva
has been implicated as the major vehicle of KSHV transmission
from which children get infected within and outside of households
* Corresponding author at: Department of Biochemistry, University of Nebraska-
Lincoln, Lincoln, NE, USA. Tel.: +1 402 472 4581.
E-mail address: jwest2@unl.edu (C. Wood).
https://doi.org/10.1016/j.ijid.2020.04.018
1201-9712/© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
International Journal of Infectious Diseases 95 (2020) 204–209
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
journal homepage: www.elsevier .com/ locate / i j id
(Crabtree et al., 2014). Practices like premastication of baby food,
application of saliva to wounds or using a saliva-soaked finger on
anorectal regions of constipated children have all been suggested
to increase the risk of KSHV infection in SSA (Butler et al., 2009a;
Crabtree et al., 2014). While HIV-1 infection has been identified as a
risk factors for KSHV infection in children, recent studies in adult
Ugandans and Cameroonians did not recapitulate these findings
(Minhas et al., 2008a; Butler et al., 2009a; Newton et al., 2018a;
Labo et al., 2019).
In a recent study from northern Tanzania, transfusion-
transmissible infections (TTI) contributed to 62% of all blood
donor rejection and destruction of collected blood donor samples.
Infections with hepatitis B and C, HIV-1 and syphilis were the
common causes of rejection and destruction of collected blood
donor samples (Valerian et al., 2018). Unfortunately, the preva-
lence of KSHV was not investigated, as KSHV is not routinely
screened prior to transfusions in Tanzania. Importantly, the KSHV
prevalence in the Tanzanian general population is not clear as
varying prevalence have been reported (Enbom et al., 2002;
Mbulaiteye et al., 2003). In this study, we recruited voluntary non-
remunerated blood donors to investigate the prevalence of
common infectious organisms and their association with KSHV
infection in order to fill the existing knowledge gap and ultimately
define strategies to reduce the infection.
2. Materials and methods
2.1. Study design, subjects and samples
This cross-sectional study utilized blood samples from 504
consecutively recruited, voluntary non-remunerated blood donors
in Dar es Salaam, Tanzania from February to May 2019. The blood
donation centers were located in all 5 districts of Dar es Salaam
region. The blood donors were of both genders and over 18 years of
age according to the national blood donation guidelines (United
Republic of Tanzania, 2015). Blood samples were collected in EDTA
vacutainers and plasma was isolated by centrifugation. Written
informed consent was obtained from all study participants. The
study was approved by the review boards of Tanzania National
Institute for Medical Research, Ocean Road Cancer Institute and the
University of Nebraska-Lincoln (UNL).
2.2. KSHV screening by immunofluorescence assay (IFA)
To determine KSHV serological status, an immunofluorescence
assay (IFA) was performed on plasma samples as previously
described (Minhas et al., 2008b). To reduce subjectivity in status
assignations, slides were independently read by two readers.
2.3. HIV-1, HBsAg, HCV and syphilis screening
The Tanzania National Blood Transfusion Service (NBTS)
transfusion-transmissible infections (TTIs) algorithm was used
to screen for TTIs by enzyme-linked immunosorbent assay (ELISA),
except as indicated. The Murex HIV Ag/Ab ELISAtest was used to
screen for HIV-1. A Murex HBsAg version 3.0 ELISA test was used
for HBsAg and Murex HCV Ag/Ab combination ELISA test for HCV
(DiaSorin, Saluggia, Italy) as previously described (Valerian et al.,
2018). The Espline Treponema pallidum rapid test (Mast group,
Merseyside, UK) was used to screen for syphilis as previously
described (Valerian et al., 2018).
2.4. Statistical analysis
Descriptive statistics were generated by frequency tables.
Associations between KSHV sero-status and risk factors were
analyzed by using the Pearson Chi-square test of independence.
Estimation of effect size (prevalence odds ratios), as well as the
direction and magnitude of effect, were performed using binary,
logistic regression modeling of risk factors of KSHV infection. All
study variables were included in the adjusted regression model.
Prevalence Odds Ratio (POR) and 95% confidence intervals (CI)
were reported to evaluate the risk factors of KSHV infection. All
tests were 2-tailed, and P-value <0.05 was considered statistically
significant. Data visualization, exploration and all analysis were
performed with SAS version 9.4 software (SAS Institute, Cary, NC).
3. Results
3.1. Characteristics of the study cohort
To investigate the prevalence of common infectious organisms
and their association with KSHV infection in Tanzanian blood
donors, we tested a total of 504 adults from Dar es Salaam,
Tanzania. The median age of the cohort was 31 years and ranged
between 18 and 58 years. Consistent with previous studies in
Tanzania, the majority of blood donors in Tanzania were male
(85.5%) and married (59.7%) (Elias et al., 2016; Mohammed and
Essel, 2018; Valerian et al., 2018). The main occupational activities
reported by blood donors were small business vendors (71.8%),
followed by being a student (Table 1). While the majority of the
participants (48%) were born in the coastal zone, comprised of Dar
es Salaam, Morogoro and Pwani, the entire country was
represented when considering participants’ places of birth (Fig.
1). Place of birth is particularly relevant because most infections
with KSHV occur during early childhood and therefore the
observed KSHV prevalence could be used as a surrogate prevalence
for participants’ places of birth (Minhas et al., 2008a; Cao et al.,
2014a; Crabtree et al., 2014).
3.2. Prevalence of KSHV infection in Tanzanian blood donors
KSHV infection in Tanzania has always been suspected to be high
but has not been reported from a cohort of sufficient size to provide
population estimates of seroprevalence. An immunofluorescence
assay (IFA) that detects antibodies against both latent and lytic KSHV
antigens expressed by mitogen-stimulated KSHV-infected BC3 cells
was utilized todetermine KSHVseroprevalence. Overall, 56.9% of the
participants were KSHV positive (Fig. 1). Anti-KSHV antibody
detection by IFA was not associated with the age, gender, marital
status or occupation of the blood donors.
3.3. Prevalence of transfusion-transmissible infections in Tanzanian
blood donors
Unmet needs for blood for transfusion are a cause of significant
morbidity and mortality. In Tanzania, less than a third of the actual
needs of blood is collected. A recent study showed that about 12%
of the voluntary blood donors are deferred from blood donations.
TTI are the main cause for deferrals. We investigated the common
TTIs among Tanzanian blood donors. The prevalence of HIV-1
infection in the cohort was 4.2%, close to the national average of
4.9% (TACAIDS et al., 2018). HBV and HCV infections were at 7.3%
and 3.2% respectively. Disturbingly, anti-syphilis antibodies were
common among blood donors at a higher than anticipated
frequency (14.9%) (Table 1).
3.4. Association between KSHV and other risk factors
To determine factors association with risk of KSHV infection, we
analyzed the relationship between KSHV infection and other
measured variables in the cohort. Overall, infections with more
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than one agent were rare. One individual had KSHV/HIV-1/HBV
while another one had KSHV/HIV-1/HCV. Dual infection with HIV-
1 was 2.6%, HBV 4.2%, HCV 2.4% and T. pallidum (syphilis) was 1.2%.
Importantly, co-infection with HBV, HCV or T. pallidum were not
associated with increased risk of KSHV infection (Table 1).
Although it appeared that HIV-1 infected blood donors were at
increased risk of KSHV co-infection POR = 2.8, 95% CI = 1.0–8.0, this
trend did not reach statistical significance (P = 0.06, Table 1).
Importantly, some places of birth showed significant association
with KSHV infection. Participants born in the central zone
(Dodoma and Singida) had increased risk of KSHV infection
POR = 5.7, 95% CI = 1.0–32.5 (P = 0.048, Table 1). Likewise, those
born in the lake zone (Kagera, Geita, Mwanza and Mara) had
significantly increased risk of KSHV infection POR = 6.4, 95%
CI = 1.6–25.3 (P = 0.008, Table 1). Although these differences are
statistically significant, they are based on small numbers (N = 12,
Central Zone and N = 35, Lake Zone). Overall, the prevalence of
KSHV in Tanzania is high and consistent with reports from nearby
countries.
4. Discussion
Despite the high incidence and prevalence of KS in Tanzania,
this is the first study to investigate KSHV prevalence in a cohort
derived from Dar es Salaam and to test for associated infectious
agents and risk factors of KSHV infection. The cohort sampled was
derived from volunteer blood donors in Dar es Salaam. Yet, it was
comprised of individuals who have migrated to the metropolitan
from throughout Tanzania. Based on recognition that KSHV
infection predominantly occurs in childhood in SSA, we assert
that this sampling provides a reasonable preliminary estimate of
country wide KSHV infection. Consistent with previous reports
from Tanzania and nearby countries, the overall Tanzanian KSHV
prevalence is high at 56.9%. Enbom et al, reported similar rates of
KSHV infection (48%) among urban Tanzanian blood donors nearly
two decades ago (Enbom et al., 2002). Another study conducted in
rural Tanzania around Lake Victoria at almost the same time-frame
reported even higher KSHV seroprevalence (89%) (Mbulaiteye
et al., 2003). Ethnicity could be playing a role in risk of KSHV
Table 1
Univariate and multivariate logistic regression analysis of risk factors of KSHV infection in Tanzania
Variables Univariate Multivariate
Odds ratio P-value 95% CI Odds ratio P-value 95% CI
Age N = 504
Median (range) 31 (18-58) 1.00 0.900 0.9–1.02 1.00 0.895 0.98–1.03
Gender N = 504
Female (%) 73 (14.5) – – – – – –
Male (%) 431 (85.5) 1.3 0.200 0.8–2.2 1.4 0.210 0.8–2.4
Marital status N = 504
Single (%) 199 (39.5) – – – – – –
Married (%) 301 (59.7) 0.9 0.584 0.6–1.3 0.8 0.435 0.5–1.4
Divorced (%) 4 (0.8) 2.1 0.512 0.2–20.9 2.4 0.456 0.2–24.7
Place of birth N = 504
Zanzibar (%) 14 (2.8) – – – – – –
Central (%) 12 (2.4) 5.4 0.052 1.0–29.7 5.7 0.048 1.0–32.5
Coastal (%) 242 (48.0) 2.2 0.160 0.7–6.9 2.4 0.144 0.7–7.6
Lake zone (%) 35 (6.9) 4.5 0.025 1.2–16.8 6.4 0.008 1.6–25.3
Northern (%) 56 (11.1) 2.8 0.100 0.8–9.4 3.0 0.090 0.8–10.5
Southern (%) 82 (16.3) 1.9 0.289 0.6–6.1 2.0 0.264 0.6–6.8
Southern highlands (%) 30 (6.0) 2.4 0.200 0.6–8.7 2.6 0.163 0.7–10.4
Western 33 (6.5) 3.2 0.084 0.9–11.6 3.4 0.075 0.9–12.9
Occupation N = 504
Farmers (%) 27 (5.4) – – – – – –
Fishermen (%) 2 (0.4) – 0.987 – 0.987
Health workers (%) 8 (1.6) 1.1 0.870 0.2–5.8 1.2 0.804 0.2–6.7
Public servants (%) 46 (9.1) 0.8 0.347 0.3–1.9 0.6 0.373 0.2–1.7
Students (%) 59 (11.7) 1.0 0.562 0.4–2.2 0.6 0.352 0.2–1.7
Small business (%) 362 (71.8) 0.6 0.966 0.2–1.6 1.1 0.848 0.5–2.5
HIV-1 status N = 504
Negative (%) 483 (95.8) – – – – – –
Positive (%) 21 (4.2) 2.5 0.080 0.9–6.9 2.8 0.055 1.0–8.0
HBsAg status N = 504
Negative (%) 467 (92.7) – – – – – –
Positive (%) 37 (7.3) 1.4 0.300 0.7–2.9 1.3 0.479 0.6–2.7
HCV status N = 504
Negative (%) 488 (96.8) – – – – – –
Positive (%) 16 (3.2) 1.7 0.300 0.6–4.9 1.8 0.333 0.6–5.6
Syphilis status N = 504
Negative (%) 429 (85.1) – – – – – –
Positive (%) 75 (14.9) 1.0 0.900 0.6–1.6 1.0 0.987 0.6–1.7
HBsAg – Hepatitis B surface antigen.
HCV – Hepatitis C virus.
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transmission as similarly high rates of KSHV prevalence have been
reported in rural Uganda, Xinjiang and Italy (DiGiovanna and Safai,
1981; Franceschi and Geddes, 1995; Zheng et al., 2017; Newton
et al., 2018). Differences in assays used, and sampled population
groups, could also be the reason for observed differences in KSHV
prevalence. High KSHV seroprevalence is directly related to the
high prevalence and risk of KS in the region (Globocan, 2018).
Despite the relatively small sample number form the Lake Zone in
our study (N = 35), twenty-five of those (71.4%) were KSHV
seropositive, which is consistent with previous studies from the
same region (Mbulaiteye et al., 2003; Nalwoga et al., 2019). The
observation of disproportionately high KSHV prevalence in
persons deriving from around Lake Victoria and from the Central
Zone could be due to cultural practices that predispose children to
saliva from infected individuals, but this needs to be investigated in
greater depth. Premastication of baby foods and chewing of local
herbs for wound soothing are common practices in these regions
(Butler et al., 2009a; Crabtree et al., 2014). A molecular analysis of
KSHV in Zambians households revealed that early KSHV infection
in children results from both within and outside the households
and from maternal and non-maternal sources (Olp et al., 2013).
This suggests that high KSHV burden in adults leads to high
transmission to children.
In addition, other factors could be playing a role in KSHV
infection leading to high KSHV burden in adults. Farming and
fishing activities with extended stay in lake water have all been
associated with KS previously, and are very common around Lake
Victoria (Ziegler, 1993; Ziegler et al., 1997), but would not be
common in the semi-arid dry-farming practices in the Central
Zone. Parasitic infections have been associated with high KSHV
prevalence in fishing communities on Lake Victoria islands in
Uganda (Nalwoga et al., 2019). A recent study of Cameroonian
adults also found a positive association between KSHV infection
and bathing or standing time in non-treated surface water (Labo
et al., 2019). In the Central zone, farming activities and walking
with bare feet could contribute to increased KSHV prevalence
perhaps due to currently underappreciated environmental expo-
sures that may be unique to that region (Ziegler, 1993; Ziegler et al.,
2003). Comprehensive risk factor assessments now appear to be
justified to define potential determinants that predispose KSHV
infection in these zones.
Although oral shedding of KSHV is independent of HIV-1 co-
infection, our group and others have previously reported increased
risk of KSHV infection with HIV-1 co-infection (Minhas et al.,
2008a; Bagni and Whitby, 2009). The role of HIV-1 in KSHV
infection is however, still not clear, as other studies did not find this
relationship to be significant (Newton et al., 2018a; Labo et al., 2019
Labo et al., 2019). In this cohort, neither HIV-1, HCV, HBV, nor T.
pallidum infection was significantly associated with increased risk
of KSHV infection, although a trend toward association with HIV-1
was evident. Since KSHV infection is most likely to occur in infancy,
whereas most of the other infections assessed are typically
acquired through exposure to blood/blood products or sexual
activity, the lack of association with KSHV infection appears logical.
For example, congenital syphilis is typically lethal. One exception is
HBV, which, in other regions, is frequently transmitted congeni-
tally (Wang et al., 2003; Hou et al., 2005; Degli Esposti and Shah,
2011; Borgia et al., 2012). The HBV prevalence in Tanzania is about
6% in adults (Miller et al., 1998) and ranges between 1.8% to 4% in
children (Meschi et al., 2010; Muro et al., 2013). Because HBV
prevalence in Tanzanian children is on the lower side compared to
areas where congenital infection is common, this led us to
speculate that acquisition by infants may occur at a low rate and
most HBV infections are occurring in adults. This concept needs to
be explored further. Differences in geography, ethnicities, eco-
nomics and HIV-1 prevalence in previous studies could explain the
Fig. 1. Schematic representative map of Tanzania showing KSHV prevalence by places of birth.
*Dar es Salaam, sample collection site.
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conflicting observations reported. Similar to other reports in the
region, the burden of Hepatitis B and C are still high in the
Tanzanian blood donors (Miller et al., 1998; Meschi et al., 2010;
Muro et al., 2013; Valerian et al., 2018). Unlike HIV-1 infection,
awareness of hepatitis B transmission and its consequences is low
in Tanzania (Mueller et al., 2015; Kilonzo et al., 2018). Hepatitis B
vaccination of under-fives has only started recently. All these could
explain increased prevalence of Hepatitis B infection in this
population. Moreover, we found disturbingly high anti-syphilis
antibody responses compared to previous studies in the region
despite on-going effort to reduce sexually transmitted infections in
the country. High rates of syphilis were previously reported during
the peak of HIV-1 epidemic in the 90s. In a study conducted in Dar
es Salaam blood donors in 1999, HIV-1 and syphilis were at 8.7%
and 12.7% respectively (Matee et al., 1999). Increased efforts in
community education on safe sex practices and ART, led to a
decrease in both HIV-1 and syphilis (3.8% and 4.7% respectively)
suggesting the effect of control strategies (Matee et al., 2006). The
decoupling of HIV-1 and syphilis infections in this cohort is also
contrary to a recent study of blood donors in the northern Tanzania
(Valerian et al., 2018). The observed surge in syphilis reported in
this study could be an indication of the community being less
conscious of preventative measures following reports of declining
HIV-1 prevalence or it may suggest a syphilis problem that has
become decoupled from HIV-1 infection and transmission. Further
studies are needed to clarify risk factors, other than HIV-1, that
contribute to or co-associate with syphilis infection in Dar es
Salaam.
In most African communities, men are associated with poor
health-seeking behaviors (Yeatman et al., 2018). Generally,
women are more responsive to health related messages and
tend to present to health facilities with earlier stage disease
(Yeatman et al., 2018). Consistent with previous studies on blood
donors in Tanzania, fewer women volunteered to donate blood in
this study (Enbom et al., 2002; Elias et al., 2016; Valerian et al.,
2018). Anemia in women has been reported to be one of the main
reasons for female reluctance to donate blood (Kumar Meinia and
Sawhney, 2016; Paparatnam and Rajani, 2016). Perhaps, fewer
women volunteer to donate blood in these studies because of
preconceived beliefs that they are anemic as a result of menses
(Elias et al., 2016). Well-designed qualitative and quantitative
studies are needed to determine barriers of donating blood
among Tanzanian women. Under-representation of women, age
groups and under-sampling from some Tanzanian provinces in
our cohort detracts somewhat from the absolute generalizability
of our findings. Nevertheless, the outcomes from this cohort
suggest trends that merit further exploration to understand the
regional prevalence and risk factors for KSHV infection, and
therefore, KS risk.
In summary we report high prevalence of KSHV and syphilis in
Tanzanian voluntary non-remunerated blood donors while ruling
out several co-infecting agents as risk factors for KSHV infection.
As anticipated, prevalence of KSHV infection was high but also
revealed focal areas, the Central and Lake Zones, of concentrated
prevalence. The observed trends need further exploration and
validation in larger studies with more unexplored risk factors to
define and mitigate factors that influence the prevalence KSHV
infection in Tanzania.
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